2026 American Association for Cancer Research
Preview information on Dana-Farber Cancer Institute's research presented at the 2026 AACR Annual Meeting in San Diego, CA, April 17-22, 2026.
News Releases
- Dana-Farber Researchers to Present More Than 50 Research Studies at American Association for Cancer Research Annual Meeting 2026
- Dana-Farber Phase 1 Study Explores Toxicity Reduction in Combination of Trastuzumab Deruxtecan and Olaparib in Advanced HER2-Expressing Malignancies
- Dana-Farber Phase 2 Trial Shows Deep and Lasting Responses to CAR T-Cell Therapy for High-Risk Smoldering Multiple Myeloma
Resources
Follow us on social media
- X (formerly Twitter)
- @DanaFarber Cancer Institute - Information on our expert cancer care and advanced research
- @DanaFarberNews - Your source for Dana-Farber news
- @DFBC_PedCare - Dana-Farber/Boston Children's Cancer and Blood Disorders Center
- Bluesky